Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

MindMaze Therapeutics Holding S.A. RLFTF

Set alert

Price alert · RLFTF

All alert types
0.22 USD 0.00 0.00%

At close · Aug 24

0.223 Day range 0.241
0.161 52-week range 4.88
YTD
-90.67%
1 year
-91.74%
Open
0.241
Prev close
0.223
Mkt cap
2.81M
Vol
50
Avg vol
4.40K
EPS
-1.70
P/E
-0.13
More statistics
Low
0.223
High
0.241

6M chart

Chart tools
Interval
1m5m15m30m

Signals (20)
NameDateAgo
MACD: Sell SignalAug 24, 20262 months ago
SMA: BearishAug 21, 20262 months ago
SMA: BullishAug 20, 20262 months ago
SMA: BearishAug 19, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BullishAug 6, 20262 months ago
MACD: Buy SignalJul 14, 20263 months ago
MACD: Sell SignalJul 13, 20263 months ago
RSI: OversoldJul 13, 20263 months ago
MACD: Buy SignalJul 9, 20263 months ago
RSI: OversoldJul 1, 20264 months ago
RSI: OversoldJun 26, 20264 months ago
RSI: OversoldJun 18, 20264 months ago
RSI: OversoldJun 15, 20264 months ago
SMA: BearishJun 9, 20264 months ago
SMA: BullishJun 4, 20265 months ago
SMA: BearishJun 3, 20265 months ago
MACD: Sell SignalMay 29, 20265 months ago
SMA: BullishMay 13, 20265 months ago

Financial health

Altman Z-Score

-0.79 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.9×
FY 2016: -3.0×FY 2017: -26.6×FY 2018: -183×FY 2019: -10.8×FY 2020: -84.5×FY 2021: -6.1×FY 2022: -2.3×FY 2023: -0.2×FY 2024: -3.1×FY 2025: -3.9×
FY 2016 5y median -3.1× FY 2025
P/S 60.9×
FY 2016: 3400×FY 2017: 0.0×FY 2018: 141×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 64.0×FY 2022: 18.8×FY 2023: 3.6×FY 2024: 6.3×FY 2025: 60.9×
FY 2016 5y median 18.8× FY 2025
P/B 1.0×
FY 2016: 2.3×FY 2017: 3.7×FY 2018: 3.8×FY 2019: 5.6×FY 2020: 9.9×FY 2021: 1.2×FY 2022: 0.8×FY 2023: 0.4×FY 2024: 1.4×FY 2025: 1.0×
FY 2016 5y median 1.0× FY 2025
P/FCF -3.0×
FY 2016: -17.6×FY 2017: -65.4×FY 2018: -129×FY 2019: -111×FY 2020: -36.3×FY 2021: -4.3×FY 2022: -4.6×FY 2023: -1.2×FY 2024: -17.2×FY 2025: -3.0×
FY 2016 5y median -4.3× FY 2025
EV/EBITDA -3.5×
FY 2016: -3.1×FY 2017: -42.8×FY 2018: -325×FY 2019: -86.1×FY 2020: -32.3×FY 2021: -5.2×FY 2022: -2.0×FY 2023: -0.1×FY 2024: -2.4×FY 2025: -3.5×
FY 2016 5y median -2.4× FY 2025
EV/Sales 49.0×
FY 2016: 3432×FY 2017: 0.0×FY 2018: 149×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 51.4×FY 2022: 16.2×FY 2023: 1.7×FY 2024: 4.8×FY 2025: 49.0×
FY 2016 5y median 16.2× FY 2025
FCF Yield -33.6%
FY 2016: -5.7%FY 2017: -1.5%FY 2018: -0.8%FY 2019: -0.9%FY 2020: -2.8%FY 2021: -23.3%FY 2022: -21.5%FY 2023: -82.3%FY 2024: -5.8%FY 2025: -33.6%
FY 2016 5y median -23.3% FY 2025

Profitability

Gross Margin -163.1%
FY 2016: -1306.7%FY 2017: 0.0%FY 2018: 90.3%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 77.4%FY 2022: 79.4%FY 2023: 71.2%FY 2024: 69.4%FY 2025: -163.1%
FY 2016 5y median 71.2% FY 2025
Operating Margin -1637.9%
FY 2016: -109926.7%FY 2017: 0.0%FY 2018: -88.5%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1033.0%FY 2022: -855.8%FY 2023: -1837.0%FY 2024: -224.4%FY 2025: -1637.9%
FY 2016 5y median -1033.0% FY 2025
Net Margin -1543.0%
FY 2016: -112226.7%FY 2017: 0.0%FY 2018: -77.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -1045.0%FY 2022: -835.2%FY 2023: -1627.4%FY 2024: -203.4%FY 2025: -1543.0%
FY 2016 5y median -1045.0% FY 2025
ROE -25.8%
FY 2016: -75.7%FY 2017: -13.8%FY 2018: -2.0%FY 2019: -52.2%FY 2020: -11.7%FY 2021: -19.1%FY 2022: -34.9%FY 2023: -188.0%FY 2024: -46.7%FY 2025: -25.8%
FY 2016 5y median -34.9% FY 2025
ROIC -25.5%
FY 2016: -53.8%FY 2017: -5.8%FY 2018: -1.4%FY 2019: -39.4%FY 2020: -12.6%FY 2021: -14.4%FY 2022: -27.2%FY 2023: -138.5%FY 2024: -33.9%FY 2025: -25.5%
FY 2016 5y median -27.2% FY 2025
ROA -19.2%
FY 2016: -53.6%FY 2017: -9.3%FY 2018: -1.2%FY 2019: -37.6%FY 2020: -10.0%FY 2021: -13.8%FY 2022: -26.9%FY 2023: -128.5%FY 2024: -32.2%FY 2025: -19.2%
FY 2016 5y median -26.9% FY 2025

Growth (YoY)

Revenue -92.4%
FY 2016: -94.1%FY 2017: -100.0%FY 2018: 0.0%FY 2019: -100.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 83.1%FY 2023: -0.8%FY 2024: 39.5%FY 2025: -92.4%
FY 2016 FY 2025
Operating Income 44.3%
FY 2016: -331.8%FY 2017: 89.5%FY 2018: 71.2%FY 2019: -2312.4%FY 2020: 24.7%FY 2021: -277.6%FY 2022: -51.7%FY 2023: -113.0%FY 2024: 83.0%FY 2025: 44.3%
FY 2016 FY 2025
EPS (diluted) 65.0%
FY 2016: -9537.7%FY 2017: 89.1%FY 2018: 85.3%FY 2019: -1568.6%FY 2020: 8.5%FY 2021: -196.9%FY 2022: -24.4%FY 2023: -74.0%FY 2024: 83.6%FY 2025: 65.0%
FY 2016 FY 2025
Free Cash Flow -325.5%
FY 2016: 59.4%FY 2017: 59.5%FY 2018: 47.3%FY 2019: -17.8%FY 2020: -2407.4%FY 2021: -170.8%FY 2022: 50.1%FY 2023: 26.7%FY 2024: 82.9%FY 2025: -325.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.2×
FY 2016: 0.4×FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 7.0×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 2.6×FY 2024: 4.0×FY 2025: 1.2×
FY 2016 5y median 2.6× FY 2025
Quick Ratio 1.1×
FY 2016: 0.4×FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 6.3×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 2.6×FY 2024: 3.7×FY 2025: 1.1×
FY 2016 5y median 2.6× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: -0.0×FY 2017: -0.5×FY 2018: -16.9×FY 2019: -0.9×FY 2020: 1.9×FY 2021: 1.3×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.8×FY 2025: 0.9×
FY 2016 5y median 0.8× FY 2025
Interest Coverage -37.4×
FY 2016: -5496×FY 2017: -19.7×FY 2018: -3.6×FY 2019: -90.0×FY 2020: -90.8×FY 2021: -43.0×FY 2022: -334×FY 2023: -336×FY 2024: -87.8×FY 2025: -37.4×
FY 2016 5y median -87.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31